Results 221 to 230 of about 15,133,243 (346)

The influence of ROS1 fusion partners and resistance mechanisms in ROS1‐TKI‐treated non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga, Christa Dijkhuizen, Patrick Korthuis, Wim Timens, Harry Groen, Jeroen Hiltermann, Anke van den Berg, Lyndsay Drayer, Anthonie van der Wekken   +8 more
wiley   +1 more source

Comparison of teacher-standardized patients and peer role-play in assessing medical students' history-taking skills. [PDF]

BMC Med Educ
Wei Y, Deng N, Zheng H, Guo H, Zhang H, Li B, Wu D, Wei L, Si X.   +8 more
europepmc   +1 more source

Review Of The Medieval Spains By B. F. Reilly [PDF]

, 1995
Bensch, Stephen P.
core   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source

Adherence to the diet with higher protein quality reduces the risk of colorectal cancer: results from a population-based prospective study. [PDF]

Front Nutr
Feng D, Wen K, Xue J, Xiao Y, Gu H, Peng L, Luo Y, Xiang L, Wang Y, Liu D.   +9 more
europepmc   +1 more source

Review Of Cultures Of Power: Lordship, Status, And Process In Twelfth-Century Europe Edited By T. N. Bisson [PDF]

, 1997
Bensch, Stephen P.
core   +1 more source

Tumor‐agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell‐free DNA fragmentomics

Molecular Oncology, EarlyView.
We evaluated circulating tumor DNA (ctDNA) detection in advanced pancreatic cancer using DNA methylation, cell‐free DNA fragment lengths, and 5′ end motifs. Machine learning models were trained to estimate ctDNA levels from each feature and their combination.
Morten Lapin, Kjersti Tjensvoll, Karin Hestnes Edland, Satu Oltedal, Herish Garresori, Bjørnar Gilje, Saga Ekedal, Trygve Eftestøl, Jan Terje Kvaløy, Filip Janku, Oddmund Nordgård   +10 more
wiley   +1 more source

Reliability of self-reported medical history and selected health characteristics in the environmental health study for Western New York cohort. [PDF]

Prev Med Rep
Rees S, Berhalther LT, Olson J, Mu L, Bonner MR.   +4 more
europepmc   +1 more source

XXV.—Contributions to the history of the phosphorus-bases [PDF]

Augustus William Hofmann
openalex   +1 more source

France: French Empire To 1789 [PDF]

, 2003
DuPlessis, Robert S.
core   +1 more source